SynAct Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2022-12-14 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 9 179 | 79 | SEK | 725 141 | 2022-12-11 |
| 2023-01-13 | SynAct Pharma AB | Patrik Renblad | Chief Financial Officer (CFO) | Allotment | 90 000 | 0 | SEK | 0 | 2023-01-12 |
| 2023-01-17 | SynAct Pharma AB | Jeppe Øvlesen | Chief Executive Officer (CEO)/Managing Directory | Subscription | 13 825 | 62,6 | SEK | 865 445 | 2023-01-15 |
| 2023-01-17 | SynAct Pharma AB | Jeppe Øvlesen | Chief Executive Officer (CEO)/Managing Directory | Subscription | 1 161 777 | 62,6 | SEK | 72 727 240,2 | 2023-01-15 |
| 2023-01-17 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Allotment | 90 000 | 0 | SEK | 0 | 2023-01-12 |
| 2023-01-17 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Subscription | 32 917 | 62,6 | SEK | 2 060 604,2 | 2023-01-15 |
| 2023-01-17 | SynAct Pharma AB | Thomas Jonassen | Member of the Board of Directors | Subscription | 15 355 | 62,6 | SEK | 961 223 | 2023-01-15 |
| 2023-01-18 | SynAct Pharma AB | Torbjörn Bjerke | Chairman of the Board of Directors | Subscription | 15 355 | 62,6 | SEK | 961 223 | 2023-01-15 |
| 2023-01-18 | SynAct Pharma AB | James Knight | Other member of the company's administrative, management or supervisory body | Subscription | 77 452 | 62,6 | SEK | 4 848 495,2 | 2023-01-15 |
| 2023-06-01 | SynAct Pharma AB | Björn Westberg | Chief Financial Officer (CFO) | Allotment | 65 000 | 0 | SEK | 0 | 2023-05-31 |
| 2023-06-06 | SynAct Pharma AB | Thomas Jonassen | Member of the Board of Directors | Allotment | 65 000 | 0 | SEK | 0 | 2023-05-31 |
| 2023-06-06 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Allotment | 65 000 | 0 | SEK | 0 | 2023-05-31 |
| 2023-06-07 | SynAct Pharma AB | Torbjörn Bjerke | Chief Executive Officer (CEO)/Managing Directory | Allotment | 200 000 | 0 | SEK | 0 | 2023-05-31 |
| 2023-06-16 | SynAct Pharma AB | Thomas Jonassen | Chairman of the Board of Directors | Acquisition | 6 250 | 73,4 | SEK | 458 750 | 2023-06-14 |
| 2023-06-16 | SynAct Pharma AB | Thomas Jonassen | Chairman of the Board of Directors | Acquisition | 6 350 | 74,8 | SEK | 474 980 | 2023-06-15 |
| 2023-06-16 | SynAct Pharma AB | Thomas Jonassen | Member of the Board of Directors | Disposal | 230 000 | 67,5 | SEK | 15 525 000 | 2023-06-12 |
| 2023-06-19 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Acquisition | 526 | 74,3 | SEK | 39 081,8 | 2023-06-15 |
| 2023-06-19 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Acquisition | 435 | 74,4 | SEK | 32 364 | 2023-06-15 |
| 2023-06-19 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Acquisition | 85 | 74,3 | SEK | 6 315,5 | 2023-06-15 |
| 2023-09-06 | SynAct Pharma AB | Björn Westberg | Chief Financial Officer (CFO) | Acquisition | 10 000 | 16,49 | SEK | 164 900 | 2023-09-04 |